BioWorld MedTech

Sep. 18, 2015

View Archived Issues

India/China Talent War: Brain drain or research exchange? China, India sharing and competing

Inside the Beltway: CMS proposes to retain CED for PET imaging for bone metastases

Agreements/contracts: Sequenom gets coverage for prenatal diagnostics

World in Review: Qiagen reports launch of careHPV, CE mark for self-collection claim

Court Report: Medical diagnostics chairman charged in stock manipulation scheme

Products

People in Places

Briefly noted

MDD's Diagnostics Extra

China ripe with opportunity: Ativa Medical brings in $15M in Series B equity funding

The emerging health care market in China has been a significant driver in Ativa Medical (St. Paul, Minn.) closing its Series B funding round. Read More

Clinicians urged to PICC up Guide: Researchers create 'MAGIC' guide to using devices for vascular access

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

Gene replacement rescues autism-related phenotypes in mice

BioWorld Science

Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results

BioWorld

Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...